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Abstract
Purpose Active exercise with compression therapy (AECT) is
a standard treatment for gynecological cancer-related lower-
limb lymphedema (LLL) in clinical situations. However, there
is insufficient evidence regarding the immediate effects of the
use of AECT on LLL. The purpose of this study was to eval-
uate the immediate effects of AECT on LLL.
Methods Participants in this randomized controlled crossover
trial comprised 23 women with LLL who completed high-
load AECT, low-load AECT, and compression-only therapy
(CT). AECTwas performed on a bicycle ergometer with short
stretch bandages. Each intervention was performed for
15 min, with successive interventions separated by a 1-week
washout period. Lower-limb volume was assessed using a
Perometer™ sensor (Pero-system, Wuppertal, Germany).
General symptoms (pain and heaviness) and skin symptoms
(pitting and stiffness) were assessed using a visual analog
scale and palpation, respectively. Measurements were taken
before and after each intervention. Analysis of variance using
linear mixed-effect modeling was used for statistical analyses.
Results Volume decrement differed significantly between all
three interventions (P < 0.05). Lower-limb volume was sig-
nificantly reduced after high-load AECT compared to that
after CT. General symptoms and skin symptoms were similar
across the three interventions, but severity of pre-intervention
skin symptoms correlated significantly with volume decre-
ment after high- and low-load AECT. High-load AECT using
the bicycle ergometer was more effective than CT for decreas-
ing lower-limb volume.
Conclusions These results suggest that high-load AECT has
marked effects on severe LLL.
Keywords Gynecological cancer . Lymphatic system
insufficiency . Rehabilitation . Ergometer exercise
Introduction
Lymphedema is a progressive chronic condition characterized
by accumulation of fluid in the tissue spaces resulting from
lymphatic system insufficiency and deranged lymph transport
[1]. A prevalence of 20–27.2% has been reported for second-
ary lower-limb lymphedema (LLL) in patients who have un-
dergone radical interventions, including pelvic lymph node
dissection, radiation therapy, and/or chemotherapy, for gyne-
cological cancer [2–4]. LLL has negative impacts on house
work [5], physical activity [5, 6], mobility [6, 7], social activ-
ities [5, 7, 8], and psychological well-being [7]. If patients
with LLL are not properly managed, the LLL will become
progressively worse, causing disability in activities of daily
living (ADL) [5, 7] and declines in quality of life [5, 7–9].
Prevention, early diagnosis, and early treatment are thus cru-
cial in the management of lymphedema.
Complex decongestive physiotherapy (CDP) is widely car-
ried out in the clinical setting as a standard treatment and
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generally involves a two-stage treatment program that com-
prises intensive and supportive phases [1]. The first, intensive
phase consists of skin care, manual lymph drainage (MLD),
multi-layered compression bandaging, and exercise with com-
pression. The second, supportive phase consists of skin care,
self-MLD, compression by an elastic garment, and continued
exercise with compression to conserve the results obtained in
the first phase.
Several studies have examined the effects of active exercise
with compression therapy (AECT) on upper-limb lymphede-
ma (ULL). Gautam et al. showed the effects of an 8-week
home exercise program comprising resistance training and
stretching on decrements in limb volume [10]. Kim et al. also
reported volume decrements with an 8-week intervention that
added resistance training to CDP [11]. Furthermore, Jeffs et al.
revealed the effects of 26-week home-based resistance train-
ing on volume decrements [12]. Concerning immediate re-
sults, the effects of AECT comprising four 12-min sessions
of exercise on lymphedema related to breast cancer [13] and of
gentle arm exercise on ULL [14] have been reported.
Consequently, long- and short-term AECTs are beneficial to
ULL in terms of volume decrement.
On the other hand, while Katz et al. showed the feasibility
of resistance training, no reports have described the long- and
short-term effects of AECT on LLL [15]. We therefore fo-
cused on the immediate effects of AECT and tried to clarify
appropriate modalities such as exercise intensity, timing, and
type.
The purpose of this study was to evaluate the immediate
effects of AECT performed using a bicycle ergometer on LLL.
Methods
Study design
This was a randomized controlled crossover trial to evaluate
the immediate effects of AECT performed on a bicycle er-
gometer with short stretch bandages on LLL. Participants
completed high-load AECT, low-load AECT, and
compression-only therapy (CT) in a randomized order, with
the timing of the first intervention defined as period 1, the
second one as period 2, and third one as period 3. Six patterns
of intervention order were applied, with randomization in
blocks of six using computer-based random number tables to
eliminate any effects of order. Each intervention was per-
formed for 15 min, and the three interventions were each
separated by a 1-week washout period to eliminate any carry-
over effects [14]. Measurements were taken before and after
each intervention (Fig. 1).
The study protocol was approved by the ethics committee
at Keio University Hospital.
Participants
Patients who had been diagnosed with secondary lymphede-
ma were screened for eligibility and recruited by rehabilitation
physicians from cancer rehabilitation or lymphedema outpa-
tient clinics at Keio University Hospital. Informed consent
was obtained from all individual participants included in the
study prior to enrolment. Inclusion criteria included (1) diag-
nosis with gynecological cancer (stages I–IV), (2) history of
treatment for gynecologic cancer, (3) age 20–80 years, and (4)
ability to perform exercise on a bicycle ergometer. Exclusion
criteria were (1) difficulty with communicating, (2) cellulitis,
(3) leakage of lymphatic fluid, (4) deep venous thrombosis,
(5) severe aneurysm, (6) severe heart disease, or (7) pulmo-
nary embolism.
Sample size was calculated using sample size calculation
software (G*Power version 3.1.9.2 for Windows; http://www.
gpower.hhu.de). The sample size was based on the change in
lymphedema as indicated by volume [13]. With effect size
calculated from mean and standard deviation, the statistical
power and statistical level of significance for the study were
set at 0.8, and 0.05, respectively, and the sample size for each
group was calculated as 13. However, the effect size in this
study seemed smaller than in the previous study, because the
intervention time was shorter. In consideration of this and a
potential 10% loss to follow-up, we sought to recruit 20
patients with lymphedema to provide adequate power.
Outcome assessments
Age, body mass index (BMI), cancer type, treatment, and
lymphedema staging according to the International Society
of Lymphology (ISL) were collected from medical records.
ISL stages were defined as follows: stage I, accumulation of
tissue fluid that subsides with limb elevation; stage II, limb
elevation alone rarely reduces swelling and pitting is manifest;
late stage II, may or may not be pitting, as tissue fibrosis is
more evident; or stage III, tissue is hard and pitting is absent,
with skin changes such as thickening, hyperpigmentation, in-
creased skin folds, fat deposits, and warty overgrowths.
Lower-limb volume, general symptoms, and skin symptoms
were evaluated pre- and immediately post-intervention with-
out bandaging in each intervention.
Lower-limb volume
Lower-limb volume was measured using the Perometer-type
1000M™ sensor (Pero-system, Wuppertal, Germany), fol-
lowing the protocol of Jeffs et al. [12]. The Perometer uses
infrared light to scan images of the limb. Formeasurement, the
patient stands with one limb inside and the other outside the
frame. Infrared light transmitters located on two sides of the
frame project light towards photo sensors on the opposing two
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sites, and the limb effectively blocks transmission of the light
from one side of the frame to the other, creating an electronic
image. As the frame is moved along the limb, a series of
images is recorded every 0.5 cm, creating limb size and vol-
ume [16].
Measurement was performed twice and mean volume was
calculated. When a difference of more than 10% was seen
between the measurements, another measurement was made.
After the measurement, data were uploaded to a personal com-
puter (Lets-note™; Panasonic, Windows Vista Business,
Osaka, Japan) and lower-limb volume was calculated using
the PeroPlus™ software (JUZO, Cuyahoga Falls, OH).
General symptoms: pain and heaviness
Pain and heaviness were measured using a visual analog scale
(VAS). On a 100-mm horizontal line, the scale was anchored
by “no pain” (score 0) and “worst imaginable pain” (score
100) for pain and “no heaviness” (score 0) and “worst imag-
inable heaviness” (score 100) for heaviness [17].
Skin symptoms: skin stiffness and pitting edema
Skin stiffness was evaluated by palpation, or pinching the
skin, at four levels, defined as follows: 0, soft; 1, slightly hard;
2, moderately hard; or 3, severely hard or fibrosis. Pitting
edema was evaluated at three levels by palpation, pressing
on the skin for 5 s, defined as follows: 0, pitting absent; 1,
pitting present for ≤5 s; and 2, pitting present for >5 s. The
same physical therapist who had already received lymphede-
ma therapist training in Japan performed the palpation.
Measurements were made at medial sites 10 cm proximal to
the knee (AK10) and 10 cm distal to the knee (BK10) and on
the dorsal aspect of the foot. Total scores for the three sites
were adopted for measurements.
Maximum muscular strength of the lower limb
Prior to the first intervention, maximum muscular strength of
the lower limb was measured using the isokinetic mode of a
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Fig. 1 Study design: the randomized controlled crossover trial. Each
intervention was performed for 15 min, and the three interventions were
separated by a 1-week washout period to eliminate any carryover effects.
Measurements were taken before and after each intervention. Six patterns
of intervention order were applied, with randomization in blocks of six
using computer-based random number tables to eliminate order effects
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Engineering, Tokyo, Japan). Maximum muscular strength of
the lower limb was defined as the maximal peak torque, ped-
aling at a rate of 50 rpm.Measurements were performed twice,
taking the higher value for analysis.
Interventions
All participants took part in the three interventions, compris-
ing high-load AECT, low-load AECT, and CT in a rehabilita-
tion room at Keio University Hospital.
In high- and low-load AECT, multi-layered compres-
sion bandaging was performed with the patient in a
supine position. A foam padding bandage (Artiflex®;
BSN Medical, Rue Guillaume, Luxembourg) on a cotton
tube stockinette (Tricofix®; BSN Medical) was wrapped
around the lower limb. Next, six short stretch bandages
(Comprilan®; BSN Medical) were sequentially wrapped
around the limb with the first bandage starting at the
foot, the second two bandages starting at the calf, the
third bandage starting just below the knee, the fourth
bandage starting at the thigh, and the fifth and sixth
bandages covering the whole limb.
All bandaging was performed by the same physical thera-
pist, who had already received lymphedema therapist training
in Japan, so that sub-bandage pressure at the calf was main-
tained around 40 mmHg using the Kikuhime™ pressure sen-
sor (TT Meditrade, Sorø, Denmark), which can measure the
sub-bandage pressure of bandages.
Active exercise was then performed using the training
mode of the Strength Ergo™240 bicycle ergometer. Exercise
intensity was set at 10% of the maximum extension muscular
strength of the lower limb as evaluated at baseline for high-
load AECT and 5% for low-load AECT. Anaerobic threshold
(AT) is one of the indices of exercise intensity, and energy
supply is provided by aerobic mechanisms at less than AT.
A previous study using the Strength Ergo™240 bicycle er-
gometer showed that muscular extension strength of the lower
limb required in ATwas approximately 12% of the maximum
extension muscular strength of the lower limb [18]. Exercise
intensities were thus set at 10 and 5% of the maximum exten-
sion muscular strength of the lower limb (i.e., less than AT) so
that all participants would be able to perform the exercise. The
position of the seat was adjusted according to height and sit-
ting height, so that activity of the gluteal muscles did not
exceed that of the lower limbs. Participants were instructed
to pedal the ergometer at 50 revolutions/min for 15 min [17].
Exercise duration varied from 15 to 60min in previous studies
[12, 19, 20]. As patients with LLLmay not be able to continue
exercise for that long, the duration of exercise was set at
15 min in the present study.
During CT, participants were instructed to maintain a sit-
ting position for 15 min.
Statistical analyses
The Wilcoxon signed-rank test was used to analyze pre- and
post-intervention changes in lower-limb volume, general
symptoms, and skin symptoms. Analysis of variance using
linear mixed-effect modeling was used to compare the effects
of three interventions (high-load AECT, low-load AECT, and
CT) and time (periods 1, 2, and 3). Least square mean (LSM)
changes in lower-limb volume and percentage changes in
VAS scores for general symptoms (pain and heaviness) and
skin symptoms (skin stiffness and pitting edema) were used to
gauge effects of the intervention. Spearman’s rank correlation
was used to compare the severity of pre-intervention skin
symptoms (skin stiffness and pitting edema) with decrements
in lower-limb volume.
Values of P < 0.05 were considered statistically significant.
Data were analyzed using the Statistics version 19 software
(IBM SPSS, Chicago, IL).
Results
We enrolled 23 patients (25 limbs), of whom 22 patients (23
limbs) completed the intervention and evaluation. Two pa-
tients chose to drop out of the study before completion.
Mean age was 60.9 ± 8.3 years and mean BMI was
22.8 ± 3.7 kg/m2. The underlying pathology was endometrial
cancer in ten patients (45.4%), ovarian cancer in eight patients
(36.4%), and cervical cancer in four patients (18.2%). All
participants underwent surgery and half received chemother-
apy. Lymphedema staging was performed according to the
International Society of Lymphology (ISL) criteria, with stage
II in 18 patients (78.3%) and late stage II in 5 patients (21.7%).
Lower-limb volume
Significant reductions in lower-limb volume were seen for all
interventions from pre- to post-intervention (high-load AECT,
P = 0.02; low-load AECT, P = <0.01; CT, P = <0.01).
LSM changes in lower-limb volume differed significantly
among the three interventions (P= 0.04), and LSM changes in
lower-limb volume were significantly higher with high-load
AECT than with CT (P = 0.02) (Table 1). Although LSM
changes in lower-limb volume were significantly higher for
period 1 than for period 2 (P = 0.04) and period 3 (P < 0.01),
no significant interactions were seen between intervention and
period (P = 0.79).
General symptoms: pain and heaviness
Significant improvements were seen in pain (high-load
AECT, P < 0.01; low-load AECT, P = 0.01; CT, P < 0.05)
and heaviness (high-load AECT, P < 0.01; low-load AECT,
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P < 0.01; CT, P < 0.01) with all interventions from pre- to
post-intervention.
No significant differences existed in LSM percentage
changes in pain and heaviness between the three interventions
(P = 0.22 and P = 0.15) (Table 1) and periods (P = 0.82 and
P = 0.23).
Skin symptoms: skin stiffness and pitting edema
Although no significant improvement of skin stiffness (high-
load AECT, P = 0.16; low-load AECT, P = 1.00; and CT,
P = 1.00) was seen with any interventions from pre- to post-
intervention, a significant difference in pitting edema (high-
load AECT, P = 0.03; low-load AECT, P < 0.05; CT,
P = 0.03) was observed with all interventions.
No significant differences in LSM percentage change in
skin stiffness or pitting between the three interventions
(P = 0.47 and P = 0.84) (Table 1) and periods (P = 0.47
and P = 0.42) were observed.
Figure 2 shows that the severity of pre-intervention skin
stiffness correlated significantly with changes in lower-limb
volume with high-load (r = 0.66, P < 0.01) and low-load
AECT (r = 0.53, P < 0.01), but not with CT (r = −0.04,
P = 0.86), while severity of pre-intervention pitting correlated
significantly with changes in lower-limb volume under high-
load (r = 0.47, P = 0.02) and low-load AECT (r = 0.45,
P = 0.03), but not under CT (r = −0.31, P = 0.15).
Discussion
No previous reports have provided data regarding the imme-
diate effects of AECTon LLL. AECT for LLL thus lacks clear
evidence regarding appropriate exercise intensity, timing, or
type. Our study represents the first report of a randomized,
controlled, crossover trial to evaluate the immediate effects
of AECT on LLL. Changes in lower-limb volume were sig-
nificantly greater with high-load AECT than with CT.
Severity of skin stiffness and pitting edema symptoms pre-
intervention correlated significantly with the volume decre-
ment under both high- and low-load AECT.
Interventions
In our study, multi-layered compression bandaging using
short stretch bandages was adopted as a compression therapy.
Damstra et al. reported median sub-bandage pressure imme-
diately after application as 64 mmHg [21]. We applied a pres-
sure of 40 mmHg, because a sub-bandage pressure exceeding
40 mmHg is recommended to counteract intravenous pressure
in the antigravity position [22], and sub-bandage pressure
rises during exercise [18]. To reduce the unevenness of the
sub-bandage pressure in each participant, measurements were
made at the facies posterior cruris using Kikuhime™ pressure
sensors (TT Meditrade), which provide a digital output from
pressure transducers comprising an air-filled pressure sensor
and the device. The accuracy and precision of Kikuhime™
have already been reported [23].
Concerning the exercise modality, we considered that it
was reasonable for patients with lymphedema to perform the
exercises. In our study, active exercise therapy was performed
on a bicycle ergometer, which offers some benefits. First, this
modality is safe because of the low risk of falls. During ped-
aling, muscle activity of the whole lower limb is involved
[24]. In addition, pedaling reportedly places less stress on
the knee joint than muscle strengthening exercises of the
quadriceps with weight loading and squats [25].
This study involved a randomized crossover design in
which participants completed three interventions separated
by 1-week washout periods. Moseley et al. showed that the
Table 1 Mean changes in least square mean (LSM) from pre-intervention to post-intervention for lower-limb volume and general and skin symptoms
Outcomes Mean change (95%CI) P
High-load AECT Low-load AECT CT P1 P2 P3 Overall P
Lower-limb volume 62.5 ± 15.3 (31.7–93.3) 50.0 ± 15.2 (19.5–80.6) 18.5 ± 15.0 (−11.6–48.6) 0.02 0.08 0.48 0.042
Pain 32.8 ± 8.9 (15.0–50.6) 24.1 ± 8.9 (6.4–41.7) 12.0 ± 8.6 (−5.4–29.2) 0.09 0.31 0.47 0.22
Heaviness 47.2 ± 7.8 (34.2–65.6) 43.4 ± 7.7 (27.9–60.0) 33.5 ± 7.6 (18.2–48.9) 0.06 0.24 0.44 0.15
Skin stiffness 2.1 ± 1.4 (−0.7–4.9) 0.0 ± 1.4 (−2.8–2.8) 0.0 ± 1.4 (−2.7–2.7) 0.29 1.00 0.29 0.47
Pitting 4.4 ± 2.3 (−0.2–9.1) 3.7 ± 2.3 (−0.9–8.3) 5.5 ± 2.3 (1.0–10.0) 0.72 0.56 0.82 0.84
Mean changes in LSMwere estimated on the basis of analyses of variance using linear mixed-effect modeling. LSM changes of lower-limb volume and
percentage changes in general symptoms including pain and heaviness and skin symptoms including skin stiffness and pitting edema were calculated as
effects of intervention
P1 high-load AECT versus CT, P2 low-load AECT versus CT, P3 high-load AECT versus low-load AECT, High-load AECT bicycle ergometer with
compression therapy, with intensity set at 10% of maximum extension muscular strength of the lower limb, Low-load AECT bicycle ergometer with
compression therapy, with intensity set at 5% of maximum extension muscular strength of the lower limb, CT compression-only therapy, LSM least
square mean, CI confidence interval. AECT active exercise with compression therapy, CT compression-only therapy
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reduction in arm volume induced by exercise gradually
returned, reaching the baseline volume by 60 min [14]. The
washout period in this study was thus judged as both neces-
sary and sufficient.
Decrement in lower-limb volume
Our results showed that the decrement in lower-limb volume
was significantly higher with AECT than with CT. Godoy
et al. showed immediate effects of AECT on ULL [13], while
Kim et al. [11] reported that volume reduction of the upper
limb was more effectively achieved with AECT than with CT.
The present study obtained similar results for LLL as the pre-
ceding studies for ULL.
CT with application of constant pressure to the skin has
some beneficial effects, such as reduction of gravitational in-
fluence, restraint of excessive leakage out of blood vessels,
improvement of lymph propulsion and lymphatic vessel re-
cruitment, and increased lymphatic drainage [26]. Moreover,
skeletal muscle contraction or muscle pumping in AECT can
create counterpressure in the form of expansion pressure
against the bandages and stimulates lymphatic flow [10–14,
27]. As a result, AECT achieves a greater volume decrement
for the lower limb than CT.
Our study also detected that the decrement in lower-
limb volume was greater with high-load AECT than
with low-load AECT. The higher muscle contraction
may be presumed to have created and stimulated greater
lymphatic flow under high-load AECT than under low-
load AECT.
Concerning the period, the decrement of lower-limb vol-
ume was significantly higher in period 1 than in period 2 or 3.
Because no interaction was seen between intervention and
period, and the three interventions were assigned to each
Fig. 2 Correlations between severity of pre-intervention skin symptoms
and changes in lower-limb volume. Severity of pre-intervention skin
stiffness correlated significantly with changes in lower-limb volume for
high-load (a) (r = 0.66, P < 0.01) and low-load AECT (b) (r = 0.53,
P < 0.01), but not for CT (c) (r = −0.04, P = 0.86). Severity of pre-
intervention pitting correlated significantly with changes in lower-limb
volume for high-load (a) (r = 0.47, P = 0.02) and low-load AECT (b)
(r = 0.45, P = 0.03), but not for CT (c) (r = −0.31, P = 0.15)
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period equally, period effect was canceled out and did not
affect the results.
General symptoms: pain and heaviness
Gautam et al. showed that AECT for ULL significantly im-
proved general symptoms [10]. This study showed similar
results for LLL as the preceding studies on ULL.
In patients with lymphedema, pain is caused not only
by inflammation, ischemia, complex regional pain syn-
drome, and cancer recurrence or progression, but also
by tissue distension resulting from the accumulation of
lymph fluid [27]. Reductions in lower-limb volume with
AECT result in decreased lower-limb weight and tissue
expansion. Although significant improvements in pain
and heaviness were seen with all interventions from
pre- to post-intervention, no significant differences
existed between the three interventions. Because little
difference in lower-limb volume decrement was evident
between interventions, participants might have perceived
broadly comparable levels of relief. In addition, the
VAS rating scale might have been insufficient to detect
differences between AECT and CT.
Correlation between severity of pre-intervention skin
symptoms and lower-limb volume decrement
Because lymph contains a high concentration of plasma pro-
teins such as albumin, the skin and subcutaneous tissue fibro-
sis are ongoing and harden as lymphedema becomes progres-
sively severe [27]. Although marked pitting is often evident in
ISL stage II, pitting may or may not be present as skin tissue
fibrosis becomes more evident in late stage II. Furthermore,
pitting is absent in ISL stage III.
Because all participants in our study were classified at stage
II and late stage II and displayed some skin symptoms, signif-
icant improvement of pitting was seen with all interventions
from pre- to post-intervention through the decrement in lower-
limb volume.
Although no significant difference between the three inter-
ventions was seen in pitting and skin stiffness, pre-
intervention severity correlated significantly with the lower-
limb volume decrement in AECT. This means that AECT
would be more beneficial for severe LLL. Such findings are
very important in clinical practice. AECT is more effective
than CT for LLL that involves more marked pitting edema
and/or harder skin. On the other hand, the immediate volume
decrement from AECT is comparable to that from CT in LLL
with less skin symptoms. Making treatment decisions on the
basis of the severity of skin symptoms may therefore be
warranted.
Limitations and future issues
Use of a crossover design could reduce the influence of
confounding covariates and could be statistically effi-
cient. On the other hand, although each intervention
was separated by a 1-week washout period to minimize
carryover effects, the possibility of such effects cannot
be completely ruled out. We used an original scale of
skin symptoms based on palpation in clinical practice.
Verification of psychometric properties such as reliabil-
ity, validity, and reactivity is thus necessary. We also
need to develop methods for quantitative evaluation.
Concerning the indication criteria, because no participants
in this study were at ISL stage III, the immediate effects of
AECT on that population remain unknown.
We examined the immediate effects of AECT, but long-
term effects also need to be evaluated. In addition, exercise
modalities for LLL need to be standardized by examining
exercise type, intensity, duration, and frequency.
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